All Episodes
|
159
|
John Neil

Podcast 159: Organizational Performance and Physician Engagement, with John Neil, MD

May 5, 2023

Episode Summary

In large part, 2022 was a financially perilous year for health systems across the country. As provider organizations look to cut costs and maximize revenues, delivering care through value-based models becomes even more challenging and, potentially, rewarding. Today, John Neil, MD speaks on the importance of leveraging physician engagement and clinical integration to align financial incentives and improve care outcomes.

Episode Notes

Dr. John Neil is the Executive Vice President and Chief Physician Executive and Network Strategy Officer for HonorHealth in Scottsdale, Arizona. Dr. Neil drives physician engagement throughout HonorHealth, working to ensure that physicians have input and involvement in the decision-making processes of the healthcare system. His work with clinical teams focuses on strategic initiatives, operations, clinical services and the continuum of patient care.

An interventional radiologist by clinical training, he joined HonorHealth as the organization’s senior physician leader in 2015 and has since held leadership roles with the organization's medical staff, Scottsdale Health Partners, and the HonorHealth Board of Directors. His professional experience includes serving as the chairman of Southwest Medical Imaging, a large radiology practice that has been active in ambulatory development, practice mergers and joint ventures.

Dr. Neil holds a bachelor's degree in biochemistry from the University of Kansas and graduated with honors from Washington University School of Medicine.

John Marchica, CEO, Darwin Research Group

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.

John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 200: How Health Systems Build Elite Clinical Leaders w/ Dr. Jonathan Stallkamp, CMO, Main Line Health
Podcast 199: A New Blueprint for Rural Health Care w/ Natalie L. Baggio, President, Corewell Health South
Podcast 198: Standing Strong as an Independent Health System w/ Dr. Allen Smith & Dr. Sam Ash, South Shore Health
Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD

Recommended Content

Browse Library
INsights
February 16, 2026

Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Read More
INsights
February 9, 2026

Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports

Read More
INsights
February 2, 2026

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.